 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Radisen Co. Ltd. |
| Street 1: | 401, 46, Hoam-ro 26ga-gil, Gwanak-gu |
| Street 2: | |
| City: | Seoul |
| Province: | |
| Post Code: | |
| Country: | Republic of Korea |
| Phone: | +82-70-7525-2147 |
| Organization Email: | sales@radisentech.com |
| Web Site: | http://radisentech.com/ |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 7928800581 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| 1. Mission and Main Focus of Work of RadiSen: RadiSen is dedicated to advancing global healthcare by providing cutting-edge Digital Radiography Solutions. Our mission is to create a world free of Tuberculosis (TB) and promote lung health through portable X-ray systems and AI-driven automatic image interpretation. 2. Why RadiSen is Interested in Tuberculosis: Since we leverage digital radiography and AI technology, and we do know that TB is the leading cause of death of people with HIV and also a major contributor to antimicrobial resistance. Thus, we hope to provide AI screening for underserved markets, aiming for early detection, accurate results, and improved patient outcomes. 3. What RadiSen is Doing or Planning to Do for TB Control: RadiSen's AI capabilities swiftly detect TB, Pneumonia, and chest abnormalities with around 95% accuracy in 10 seconds. Our seamless solutions integrate with existing X-ray machines, ensuring easy adoption for healthcare providers. With over 60 successful global deployments, including a collaboration in the Philippines screening 20,000 participants in three months, we are actively contributing to TB control initiatives worldwide. Our goal is to extend our impact by collaborating further to enhance TB screening and control in diverse regions. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Delivery of health services and care Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We attended the Union World Conference 2023 and met with officers and doctors from the Asia Pacific Region Conference of the International Union Against TB and Lung Disease (APRC). We discussed sponsoring APRC 2024 and exploring how RadiSen can contribute to the national TB control plan. | |
Geographical Reach | |
| Which country is your headquarters located in: | Republic of Korea |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Ethiopia India Indonesia Philippines Thailand Viet Nam |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
New Diagnostics: RadiSen's AI capabilities swiftly detect TB, Pneumonia, and chest abnormalities with approximately 95% accuracy in 10 seconds. Our seamless solutions integrate with existing X-ray machines, ensuring easy adoption for healthcare providers. With over 60 successful global deployments, mostly in Southeast Asia, including a recent collaboration in the Philippines that screened 20,000 participants in three months, we actively contribute to TB control initiatives worldwide. |
|
Declaration | |
| Declaration of interests: There are no known conflict of interest. | |
| Application date: | December 15, 2023 |
| Last updated: | August 8, 2024 |